We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGI icon
3251
Vanguard International Dividend Appreciation ETF
VIGI
$9.26B
$245K ﹤0.01%
3,090
-159
-5% -$11.7K
EWJ icon
3252
iShares MSCI Japan ETF
EWJ
$22.7B
$243K ﹤0.01%
+3,781
New +$231K
BBAI icon
3253
BigBear.ai
BBAI
$1.6B
$242K ﹤0.01%
112,959
+35,810
+46% +$58K
BIRK icon
3254
Birkenstock
BIRK
$6.89B
$241K ﹤0.01%
+4,936
New +$214K
NGM
3255
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$239K ﹤0.01%
278,704
+3,640
+1% +$3.2K
PAYS icon
3256
Paysign
PAYS
$713M
$236K ﹤0.01%
84,171
VOR icon
3257
Vor Biopharma
VOR
$1.28B
$234K ﹤0.01%
5,196
CPSS icon
3258
Consumer Portfolio Services
CPSS
$198M
$234K ﹤0.01%
24,927
+1,700
+7% +$15.9K
GPGI
3259
GPGI Inc
GPGI
$4.11B
$231K ﹤0.01%
51,606
KRMD icon
3260
KORU Medical Systems
KRMD
$159M
$228K ﹤0.01%
92,728
THRX
3261
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$228K ﹤0.01%
56,203
ORGN
3262
DELISTED
Origin Materials
ORGN
$226K ﹤0.01%
9,021
-1,799
-17% -$51.6K
RNAC icon
3263
Cartesian Therapeutics
RNAC
$260M
$224K ﹤0.01%
10,844
TALK icon
3264
Talkspace
TALK
$869M
$224K ﹤0.01%
88,164
+50,082
+132% +$101K
PMTS icon
3265
CPI Card Group
PMTS
$352M
$221K ﹤0.01%
11,534
PNRG icon
3266
PrimeEnergy Resources
PNRG
$315M
$218K ﹤0.01%
2,052
EVA
3267
DELISTED
Enviva Inc.
EVA
$215K ﹤0.01%
216,090
-41,880
-16% -$116K
KZR
3268
DELISTED
Kezar Life Sciences
KZR
$215K ﹤0.01%
22,649
-11,895
-34% -$105K
HQI icon
3269
HireQuest
HQI
$239M
$214K ﹤0.01%
13,973
LENZ
3270
LENZ Therapeutics
LENZ
$163M
$214K ﹤0.01%
11,684
CARM
3271
DELISTED
Carisma Therapeutics
CARM
$213K ﹤0.01%
72,743
VIA
3272
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$210K ﹤0.01%
22,329
SPTS icon
3273
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
$207K ﹤0.01%
7,124
DLTH icon
3274
Duluth Holdings
DLTH
$152M
$202K ﹤0.01%
37,480
MHH icon
3275
Mastech Digital
MHH
$94.5M
$200K ﹤0.01%
23,684

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.